Debenture Agreements in the Health Care Providers & Services Industry
71 Contracts & Agreements
- Aeon Global Health Corp. (1 contract)
- Aevi Genomic Medicine, Inc. (1)
- CATASYS, INC. (6)
- CBA Florida, Inc. (3)
- COLUMBIA VALLEY HEALTHCARE SYSTEMS L P (5)
- DOBI MEDICAL INTERNATIONAL INC (1)
- ENZO BIOCHEM INC (1)
- First Choice Healthcare Solutions, Inc. (1)
- HEALTH SYSTEMS SOLUTIONS INC (2)
- Healthcare Corp of America (1)
- HEALTHCARE PROVIDERS DIRECT INC. (2)
- Incannex Healthcare Ltd (1)
- INNOVUS PHARMACEUTICALS, INC. (13)
- INTRAOP MEDICAL CORP (1)
- Medical Care Technologies Inc. (2)
- MEDICAL SOLUTIONS MANAGEMENT INC. (2)
- METROPOLITAN HEALTH NETWORKS INC (1)
- Novo Integrated Sciences, Inc. (2)
- PACER HEALTH CORP (1)
- POWER 3 MEDICAL PRODUCTS INC (2)
- ProUroCare Medical Inc. (4)
- Rennova Health, Inc. (6)
- Revolutions Medical CORP (1)
- SCIVANTA MEDICAL CORP (5)
- SINOFRESH HEALTHCARE INC (2)
- Telzuit Medical Technologies, Inc. (1)
- WELLQUEST MEDICAL & WELLNESS CORP (2)
- XLR MEDICAL CORP. (1)
- Secured Convertible Debenture, dated October 14, 2024 (Incannex Healthcare Ltd, Filed With SEC on October 21, 2024)
- Form of Debenture (ENZO BIOCHEM INC, Filed With SEC on May 22, 2023)
- 15.0% ORIGINAL ISSUE DISCOUNT SENIOR SECURED CONVERTIBLE DEBENTURE DUE _________[___]1, 2024 (XLR MEDICAL CORP., Filed With SEC on October 31, 2022)
- Form of Bridge Debenture Agreement, dated as of June 24, 2019 (Rennova Health, Inc., Filed With SEC on June 25, 2019)
- Form of Bridge Debenture Agreement, dated as of June 13, 2019 (Rennova Health, Inc., Filed With SEC on June 14, 2019)
- Form of Bridge Debenture Agreement, dated as of May 12, 2019 (Rennova Health, Inc., Filed With SEC on May 15, 2019)
- FORM OF OriginalIssue Discount Debenture DUESeptember 22, 2017 (Rennova Health, Inc., Filed With SEC on June 22, 2017)
- SENIORSECURED Original issue discount CONVERTIBLE DEBENTURE DUE_________ (Rennova Health, Inc., Filed With SEC on March 16, 2017)
- OriginalIssue Discount Convertible Debenture DUEMay 2, 2017 (Rennova Health, Inc., Filed With SEC on February 8, 2017)
- 8% SEries b CONVERTIBLE DEBENTURE DUE MARCH 31, 2017 (CATASYS, INC., Filed With SEC on February 1, 2017)
- 8% SEries b CONVERTIBLE DEBENTURE DUE MARCH 31, 2017 (CATASYS, INC., Filed With SEC on December 30, 2016)
- 8% SENIOR CONVERTIBLE DEBENTURE DUE MARCH 15, 2017 (CATASYS, INC., Filed With SEC on December 23, 2016)
- INNOVUS PHARMACEUTICALS, INC. 10% DEBENTURE (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on August 15, 2016)
- INNOVUS PHARMACEUTICALS, INC. 10% DEBENTURE $24,000 San Diego, CADated as of: May 3, 2016 (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on May 16, 2016)
- AMENDMENT TO 12% ISSUE DISCOUNT CONVERTIBLE DEBENTURE DATED JULY 29, 2015 (CATASYS, INC., Filed With SEC on October 16, 2015)
- AUTHENTIDATE HOLDING CORP. 9% SENIOR SECURED CONVERTIBLE DEBENTURE (Aeon Global Health Corp., Filed With SEC on October 13, 2015)
- 12% ORIGINAL ISSUE DISCOUNT CONVERTIBLE DEBENTURE DUE January 18, 2016 (CATASYS, INC., Filed With SEC on July 31, 2015)
- 12% ORIGINAL ISSUE DISCOUNT CONVERTIBLE DEBENTURE DUE January 18, 2016 (CATASYS, INC., Filed With SEC on April 21, 2015)
- INNOVUS PHARMACEUTICALS, INC. 8% DEBENTURE $50,000San Diego, CA (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on August 14, 2014)
- INNOVUS PHARMACEUTICALS, INC. 8% DEBENTURE $50,000San Diego, CA (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on August 14, 2014)
- INNOVUS PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED 8% CONVERTIBLE DEBENTURE (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on July 23, 2014)
- 10%SECURED CONVERTIBLE DEBENTURE DUEMAY 31, 2017 (Healthcare Corp of America, Filed With SEC on June 5, 2014)
- SCIVANTA MEDICAL CORPORATION 10% Convertible Debenture Due December __, 2014 (SCIVANTA MEDICAL CORP, Filed With SEC on December 17, 2013)
- INNOVUS PHARMACEUTICALS, INC. AMENDED AND RESTATED 8% CONVERTIBLE DEBENTURE (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on November 14, 2013)
- INNOVUS PHARMACEUTICALS, INC. AMENDED AND RESTATED 8% CONVERTIBLE DEBENTURE (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on November 14, 2013)
- INNOVUS PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED 8% CONVERTIBLE DEBENTURE (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on November 14, 2013)
- 8%ORIGINAL ISSUE DISCOUNT SECURED CONVERTIBLE DEBENTURE DUEdecember 28, 2013 (First Choice Healthcare Solutions, Inc., Filed With SEC on November 14, 2013)
- INNOVUS PHARMACEUTICALS, INC. MAY 2013 AMENDMENT TO AMENDED AND RESTATED8% CONVERTIBLE DEBENTURE (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on August 13, 2013)
- Senior Secured, Convertible, Redeemable Debenture (Revolutions Medical CORP, Filed With SEC on May 21, 2013)
- INNOVUS PHARMACEUTICALS, INC. AMENDED AND RESTATED 8% CONVERTIBLE DEBENTURE (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on March 19, 2013)
- INNOVUS PHARMACEUTICALS, INC. 8% CONVERTIBLE DEBENTURE (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on March 19, 2013)
- INNOVUS PHARMACEUTICALS, INC. AMENDMENT TO 8% CONVERTIBLE DEBENTURE (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on March 19, 2013)
- INNOVUS PHARMACEUTICALS, INC. 8% CONVERTIBLE DEBENTURE (INNOVUS PHARMACEUTICALS, INC., Filed With SEC on March 19, 2013)
- SCIVANTA MEDICAL CORPORATION 8% Convertible Debenture Due August 15, 2015 (SCIVANTA MEDICAL CORP, Filed With SEC on August 21, 2012)
- MEDICAL CARE TECHNOLOGIES INC. Amended and Restated 10% Convertible Debenture Due November 29, 2014 (Medical Care Technologies Inc., Filed With SEC on July 17, 2012)
- Second Addendum to the 8% Convertible Debenture between and Scivanta Medical Corporation (SCIVANTA MEDICAL CORP, Filed With SEC on March 16, 2012)
- MEDICAL CARE TECHNOLOGIES INC. Amended and Restated 15% Convertible Debenture Due December 9, 2013 (Medical Care Technologies Inc., Filed With SEC on December 15, 2011)
- SCIVANTA MEDICAL CORPORATION 8% Convertible Debenture Due May 20, 2014 (SCIVANTA MEDICAL CORP, Filed With SEC on June 14, 2011)
- FORMOF CONVERTIBLE DEBENTURE (Aevi Genomic Medicine, Inc., Filed With SEC on November 5, 2010)
- AMENDMENT TO CONVERTIBLE DEBENTURE (Novo Integrated Sciences, Inc., Filed With SEC on April 14, 2010)
